Group 1 - Konomei (Beijing) Technology Co., Ltd. has completed several million yuan A+ round financing, led by Jiuan Medical, to accelerate commercialization and continue independent research and innovation [1] - The company, founded in 2019, focuses on the independent research and industrialization of ultra-high performance liquid chromatography (UHPLC) technology, with the core founding team having an average of nearly 20 years of experience in the life science instrument field [1] - As of April 2025, Konomei has applied for over 30 patents and software copyrights, including 6 invention patents and 14 utility model patents, along with multiple proprietary technologies [1] Group 2 - Jiuan Medical's chairman, Liu Yi, emphasizes the company's commitment to discovering and partnering with practical enterprises that can address industry pain points and lead industrial upgrades [2] - Jiuan Medical focuses on two core opportunities: deepening independent research around the "Stanford model" to activate the "engineer dividend" and seizing the wave of domestic scientific instrument production and policy support to promote import substitution in the global market [2] - Konomei's breakthroughs in the ultra-high performance liquid chromatography field have disrupted China's long-standing reliance on imports in the high-end market of this sector [2]